Abstract
Introduction. Intestinal dysbiosis (DB) often occurs in diseases of the digestive tract, in particular in chronic pancreatitis (CP). The aim of the study was investigate the effectiveness of various DB correction and its effect on the dynamics of serum free amino acids (SFAA) in patients with CP and type 2 diabetes mellitus (DM). Materials and methods of research. 82 patients with CP and type 2 diabetes were examined. All examined patients underwent general clinical studies, feces for dysbiosis, as well as determination of the level of SFAA. Patients with CP and type 2 diabetes are divided into 2 groups depending on the method of correction of DB. Results and discussion. Prescribed therapy was effective in both groups of examined patients with CP and type 2 diabetes on the severity of DB. Normalization of the intestinal microbiota in patients with CP and type 2 diabetes was accompanied by positive dynamics in the levels of SFAA. A decrease in the levels of methionine, valine, cysteine in patients of both study groups was found. Attention is drawn to the more pronounced positive dynamics in the levels of such amino acids as tryptophan, tyrosine, phenylalanine, asparagine (p<0.01), mainly in patients of group II. Conclusions. In patients with CP and type 2 diabetes, DB of mainly III and II degrees were found, which is accompanied by a violation of the levels of SFAA in these patients. Complex therapy with Bacillus coagulans and vitamin B9, B12 in combination with B. infantis 35624 in patients with CP and type 2 diabetes is an effective means of normalizing of DB, which, in turn, is accompanied by positive dynamics in the levels of SFAA (decrease of methionine, valine, cysteine and increased levels of tryptophan, tyrosine, phenylalanine).
References
Kocaba Yu.Ya., Babinec L.S. Topical aspects of the use of probiotics in colonic dysbiosis // Family medicine. — 2018. — Vol. 4 (78). — P. 85-87. (in Ukrainian)
Larin A.S., Tkach S.M. Phatogenetocheskaja rol kisechnogo disbioza v razvitii ozhirenia, insulinorezistentnosti I sacharnogo diabeta 2 tipa. Health of Ukraine // Thematic number. Gastroenterology. Hepatology. Coloproctology. — 2016. — Vol. 2 (40). — P. 20-21. (in Russian)
Huhlina O.S., Dudka I.V., Dudka T.V., Smandich V.S. Clinical efficacy of Antral® in patients with chronic pancreatitis // Health of Ukraine. — 2020. — Vol. 3. — P. 17. (in Ukrainian)
Raksha N.G., Halenova T.I., Vovk T.B., Sukhodolia S.A., Beregova T.V., Ostapchenko L.I. Proteolitic imbalance as a key factor of the development of chronic pancreatitis with and without type 1 diabetes mellitus // Visnik problem biologii i medicine. — 2019. — Vol. 3 (152). — P. 186-191. (in Ukrainian) DOI 10.29254/2077-4214-2019-3-152-186-191.
Hristich T.M., Hontsariuk D.O. Etiological factors which from the chronical pancreatitis // Zdobutki klinichnoji I eksperimentalnoji medicine. — 2018. — Vol. 3. — P. 20-27. (in Ukrainian) DOI 10.11603/1811-2471.2018.v0.i3.9221.
Fadejenko G.D., Chernishov V.A. Defeat of the gastroduodenal area in patients with diabetes mellitus: clinical and population aspects // Medicine of Ukraine. — 2011. — Vol. 7 (153). — P. 48-50. (Ukranian)
Krasnova I.N., Karpova L.A., Cherkas Yu.V. Opredelenije aminokislot v sivorotke krovi cheloveka metodom obrachenno-fazovoj visokoeffektivnoj zhidkostnoj chromatografii v rezhime izokraticheskogo eljuirovanija // Zhurnal analiticheskoj chimii. — 2000. — Vol. 55 (1). — P. 66-74. (in Russian)
Hobzej M.K., Guljchij M.V., Stepanenko A.V. et al. Type 2 Diabetes Mellitus. Unified clinical protocol for primary and secondary (specialized) medical care. — Kijiv, 2012. — 118 p. (in Ukrainian). http://ukrgastro.com.ua/klinichni-protokoli-ta-nastanovi/
Hobzej M.K., Matyuha L.F., Netjazhenko V.Z. et al. Type 2 Diabetes Mellitus. Adapted clinical guideline based on evidence. — Kijiv, 2012. — 343 p. (in Ukrainian). http://ukrgastro.com.ua/klinichni-protokoli-ta-nastanovi/
Caroline Р., Brietzke E., Rosenblat J.D. et al. Probiotics for the treatment of depressive symptoms: An anti-inflammatory mechanism? // Brain. Behavior and Immunity. — 2018. Jul 18. pii: S0889-1591(18)30304-0. DOI: 10.1016/j.bbi.2018.07.006.
Desbonnet L., Garrett L., Clarke G., Kiely B., Cryan J.F., Dinan T.G. Effects of the probiotic Bifidobacterium infantis in the maternal separation model of depression // Neuroscience. — 2010. — Vol. 170 (4). — P. 1179-1188. DOI: 10.1016/j.neuroscience.2010.08.005.